SFXN3 and acute myeloid leukemia: SFXN3 Promotes DNA Methylation in Non-M3 AML Patients at Transcription Start Sites (TSS), which Clustered in Multiple Vital Cell Functions and Accompanied by Mutations in DNMT3A and NPM1